Track record · Live as of 2026-05-23
Three pharma tenants live. One regulated clinical client in year four.
The platform isn't theoretical. Three pharma brands are live on brand-as-model today, and a multi-vertical 503A clinical operation has been running on the rail for four years. Here is the live evidence, the architecture, and what a new tenant inherits.
Long-running regulated engagement · 4 years
Eternal · multi-vertical regulated clinical content
Eternal Hair & Esthetics is a multi-vertical clinical operation under FDA 503A compounding regulations. Three verticals (hair, esthetics, longevity), named physicians (Dr. Tawfik, Dr. Elder, Dr. Kirten), Allergan Top 250 credential, two physical clinics. Every piece of patient-facing content runs through the OVYN platform. Three pharma tenants are now live on the same rail with brand-as-model on top (see below).
Engagement profile
Live since: 2026
Verticals managed: 3 (hair, esthetics, longevity)
Brand brain · canon facts: 132 indexed
Compliance pass rate: 97.5% (39/40 ad variants)
What's actually running for them
Same engine. Same rail. Same workflow as your tenant would be.
AI content generationLive · production
Brand-trained version generator across reels, carousels, statics, eBlasts, email banners, landing pages. Fed by their approved claims, indication scope, voice rules.
Compliance pre-check railLive · production
FDA 503A compounding rules + state-specific cosmetic/medical regulation rules + their internal forbidden-phrase list. Every output scored before staff review.
Multi-channel deploymentLive · production
MLR-cleared output exports in channel-ready format for the team to ingest into Meta, Instagram, LinkedIn, TikTok, Reddit, or the brand CMS. Direct-API publishing is scoped per engagement during onboarding.
Performance loopLive · production
Engagement signal flows back from each channel. Top 25%/bottom 25% attribute analysis. The system learns what works for their audience and tunes future generations.
Competitive intelligenceLive · production
Standing weekly signal across competitor paid social, GEO mentions in ChatGPT/Perplexity, organic search rank for their condition cluster. Auto-generated content briefs from gaps.
Workflow + approvalsLive · production
Multi-stage approval: voice check → compliance rail → brand QA → final approval → deployment. Audit trail on every execution.
What's the same · what's new for pharma
The platform mechanics translate. The brand brain rebuilds per indication.
✓ Translates directly
- The generation engine itself
- The compliance rail architecture
- Multi-channel deployment pipeline
- Performance feedback loop
- Workflow + audit trail
- Competitive intelligence harvester
- Brand-brain configuration framework
⚙ Built fresh per pharma engagement
- FDA / OPDP rule set (vs 503A compounding rules)
- Per-indication claims library + ISI executions
- Veeva PromoMats connector (new)
- Veeva CRM performance integration (new)
- Field-rep Approved Email templates
- HCP-targeted vs patient-targeted voice rules
- Indication-specific audience personas
Honest framing for the pitch: three pharma tenants are now live on brand-as-model as of 2026-05-23. The platform mechanics are proven on Eternal (503A compounding, 4 years in production). The brand-as-model architecture (essence anchor, brand corpus, brand-fit scoring, per-brand text adapter, three-axis check) ships across Nourish Health, Lumen Oncology, and Product X today. A new pilot inherits the full stack.
Pharma tenants · brand-as-model · Live as of 2026-05-23
Three brands. Three brand worlds. Same architecture per brand.
The brand-as-model architecture (essence anchor, brand corpus, brand-fit, per-brand text adapter) is live across three pharma tenants as of 2026-05-23. Each brand is encoded as its own model, not a configured general model. Output reads instantly as the brand because the model was told who the brand IS before any rule. Every generation passes a three-axis check (rules, self-check, brand-fit).
Nourish Health
Pharmaceutical wholesale · compounding distributor
brain v10corpus 20brand-fit 92
“Three sourcing facts, three audits. Prescribed, not sold. Trust is the product.”
Lumen Oncology
Institutional oncology HCP archetype
brain v2corpus 17brand-fit 91
“Trial named. Limitation paired in same line. Fair-balance structural, not bolted on.”
Product X
Rare disease · anonymized
brain v2corpus 18brand-fit 86
“Small improvements may open up more possibilities. Realistic hope. No cure-talk.”
Real numbers · pulled live from the engine
What the platform has actually done.
The numbers below are real, queried from the live Eternal database on April 28, 2026. Not benchmarks, not forecasts. actual platform throughput. Eternal is a multi-vertical regulated clinical operation under FDA 503A; it's not biotech DTC, but the platform mechanics are identical to what your tenant would inherit.
Compliance pass rate
97.5%
39 of 40 ad variants cleared rail
Brand brain · canon
132
Brand facts indexed + retrievable
Standing rules
16
OPDP / brand / voice rules running on every generation
Competitors tracked
27
Across SERP, ClinicalTrials.gov, FAERS, Orange Book, OPDP letters, Open Payments, drug-shortage, GEO
Harvest runs
40
Competitive scans completed
Platform insights distilled
83
From harvested raw signal, ready for prompt context
Creative events logged
71+
Across ad visual, Higgsfield video, Ideogram, talking-head, transcription
Verticals in production
3
21 longevity · 11 hair · 7 esthetics + 1 cross-vertical
Eternal is a small operation. the platform is sized to fit it, not to fake scale. What matters is the rail mechanics work. 97.5% pass rate on ad variants and a 132-fact canon means the architecture is real, not slideware. Your pilot will show measurable cycle-time improvement on your specific brief. which is more defensible than any number above.
Want to talk to the existing client?
We can arrange a 30-min reference call once you're past the pilot stage.
Standard reference-call protocol · NDA in place, scoped questions, their commercial lead on the line. Not offered before the pilot because we don't ask references to take calls speculatively.
Forward thisOne click to the right page for whoever you need to loop in.
What's underneathArchitecture · advisors · published thinking.
Talk to us30 minutes with Maha + Zein. No deck, no sales motion. We answer your questions.
